Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6050060 | 1.00 | KEAP1 (0.39) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| Hydrochloric Acid SCHEMBL25753 | 0.99 | MEN1 (0.39) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| SCHEMBL8573016 | 0.81 | KEAP1 (0.39) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| SCHEMBL6049999 | 0.81 | KEAP1 (0.39) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| SCHEMBL896439 | 0.78 | KEAP1 (0.38) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| Hydrochloric Acid SCHEMBL28961326 | 0.78 | MEN1 (0.39) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| SCHEMBL28961321 | 0.78 | CNR2 (0.40) | KEAP1NFE2L2CHRM2CHRM1CYP2C19 | |
| SCHEMBL28927937 | 0.70 | RAB9A (0.35) | CHRM2CHRM1CYP2C19CHRM4CHRM3 | |
| Hydrochloric Acid SCHEMBL28927950 | 0.70 | RAB9A (0.34) | CHRM2CHRM1CYP2C19CHRM4CHRM3 | |
| SCHEMBL6049989 | 0.68 | CYP2C19 (0.32) | CHRM2CHRM1CYP2C19CHRM4CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1526880-B1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | BOSTON SCIENT LTD (BB) | 2012-01-18 | — | — | EP | claimed |
| US-7288084-B2 | Drug-loaded medical device | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-10-30 | — | — | US | claimed |
| JP-2006514557-A | — | — | 2006-05-11 | — | — | JP | claimed |
| EP-1526880-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2005-05-04 | — | — | EP | claimed |
| WO-2004011055-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2004-02-05 | — | — | WO | claimed |
| US-20030224033-A1 | Implantable or insertable medical devices for controlled drug delivery | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-04 | — | — | US | claimed |
| EP-4168092-B1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | BARD INC C R (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12458392-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250302814-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-10-02 | — | — | US | disclosed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | disclosed |
| WO-2025106773-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA WITH A COMBINATION OF A GLP-1 AGONIST AND A SECOND ACTIVE AGENT | APNIMED, INC. (DELAWARE) (US) | 2025-05-22 | — | — | WO | disclosed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | disclosed |
| US-12167883-B2 | Medical device including expandable muscle polymer | BARD PERIPHERAL VASCULAR, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| EP-0767659-B1 | TRANSDERMAL ADMINISTRATION OF OXYBUTYNIN | ALZA CORP (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998001125-A2 | DEXTROROTATORY ISOMERS OF OXYBUTYNIN AND DESETHYLOXYBUTYNIN IN THE TREATMENT OF GASTROINTESTINAL HYPERACTIVITY | SEPRACOR, INC. (US) | 1998-01-15 | — | — | WO | disclosed |
| EP-0767659-A1 | TRANSDERMAL ADMINISTRATION OF OXYBUTYNIN | ALZA CORPORATION (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996012477-A1 | CONTROLLED RELEASE ORAL DELIVERY SYSTEM CONTAINING OXYBUTYNIN | LEIRAS OY (FI) | 1996-05-02 | — | — | WO | disclosed |
| US-5500222-A | MIXED WITH MONOGLYCERIDE PERMEATION ENHANCER | ALZA CORPORATION (US) | 1996-03-19 | — | — | US | disclosed |
| US-5411740-A | Drug delivery | ALZA CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| WO-1993023025-A1 | TRANSDERMAL ADMINISTRATION OF OXYBUTYNIN | ALZA CORPORATION (US) | 1993-11-25 | — | — | WO | disclosed |